Security key
45781K204
- Security type / class
- Equity / SPONSORED ADS
- Total 13F shares
- 99,838
- Total 13F value
- $179,124
- Share change
- -58,351
- SEC-reported price per share
- $1.81
- Number of holders
- 9
- Value change
- -$103,610
- Number of buys
- 4
- Number of sells
- 5
Report period
Q2 2025
Institutions
9
Top holders
9
IPHA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Innate Pharma SA SEC filings
Innate Pharma SA company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45781K204
Recent filing periods:
Ownership snapshot
Top reported holders of IPHA - Innate Pharma SA - SPONSORED ADS (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Sanofi
Disclosed value leader
EXCHANGE TRADED CONCEPTS,...
Comparable rows
2/12
Latest evidence
25 Apr 2025
13D/G
13F
Lead comparable stake: 9%
10 rows are not safely comparable across share classes.
13D/G row: Sanofi
Showing 1-6 of 12 holder rows.
Quick read
Sanofi leads the comparable SEC ownership view at 9%.
2 of 12 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Sanofi's linked filing trail.
Comparable ownership
Top 2
Sanofi
9%
Bpifrance Participations SA
7.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 12 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Sanofi |
13D/G
|
9%
Reported 13D/G
· 23 Apr 2025
|
—
8,345,387 shares
|
$0 | 23 Apr 2025 |
| Bpifrance Participations SA |
13D/G
Caisse des depots et consignations
|
7.9%
Reported 13D/G
· 25 Apr 2025
|
—
7,319,429 shares
|
$0 | 25 Apr 2025 |
| EXCHANGE TRADED CONCEPTS, LLC |
13F
Company
|
—
denominator unverified
|
$111,699
62,752 shares
|
— | 31 Mar 2025 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$77,473
43,524 shares
|
— | 31 Mar 2025 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$43,195
24,267 shares
|
— | 31 Mar 2025 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$27,280
15,326 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
9
Shares
99,838
Rows available
9
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q2 2026 Across Filers
Q2 2026 holders
10
Q2 2025 holders
9
Holder diff
-1
| Investor | Q2 2026 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q2 2026 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend